ARS PHARMACEUTICALS OPERATIONS, INC. v. LUPIN INC.
2:25-cv-15123
Overview
Parties
Defendant
LUPIN PHARMACEUTICALS, INC. Operating Company
Represented By
5 Attorneys ListedGEMINI LAW LLP
COUNSEL NOT ADMITTED TO USDC - NJ BAR, 32 W 39TH STREET
GEMINI LAW LLP
COUNSEL NOT ADMITTED TO USDC - NJ BAR, 32 W 39TH STREET
GEMINI LAW LLP
COUNSEL NOT ADMITTED TO USDC - NJ BAR, 32 W 39TH STREET
GEMINI LAW LLP
COUNSEL NOT ADMITTED TO USDC - NJ BAR, 32 W 39TH STREET
LUPIN INC. Operating Company
Represented By
5 Attorneys ListedGEMINI LAW LLP
COUNSEL NOT ADMITTED TO USDC - NJ BAR, 32 W 39TH STREET
GEMINI LAW LLP
COUNSEL NOT ADMITTED TO USDC - NJ BAR, 32 W 39TH STREET
GEMINI LAW LLP
COUNSEL NOT ADMITTED TO USDC - NJ BAR, 32 W 39TH STREET
GEMINI LAW LLP
COUNSEL NOT ADMITTED TO USDC - NJ BAR, 32 W 39TH STREET
Plaintiff
AEGIS THERAPEUTICS, LLC Operating Company
Represented By
4 Attorneys ListedCOUNSEL NOT ADMITTED TO USDC - NJ BAR
COUNSEL NOT ADMITTED TO USDC - NJ BAR, DLA PIPER
COUNSEL NOT ADMITTED TO USDC - NJ BAR
COUNSEL NOT ADMITTED TO USDC - NJ BAR, DLA PIPER
MCCARTER & ENGLISH, LLP
FOUR GATEWAY CENTER, 100 MULBERRY STREET
ARS PHARMACEUTICALS OPERATIONS, INC. Operating Company
Represented By
9 Attorneys ListedMCCARTER & ENGLISH, LLP
FOUR GATEWAY CENTER, 100 MULBERRY STREET
Mintz, Levin, Cohn, Ferris, Glovsky, and Popeo, P.C.
COUNSEL NOT ADMITTED TO USDC - NJ BAR, One Financial Center
MINTZ, LEVIN, COHN, FERRIS, GLOVSKY AND POPEO, P.C.
COUNSEL NOT ADMITTED TO USDC - NJ BAR, ONE FINANCIAL CENTER
Mintz, Levin, Cohn, Ferris, Glovsky, and Popeo, P.C.
COUNSEL NOT ADMITTED TO USDC - NJ BAR, One Financial Center
Mintz, Levin, Cohn, Ferris, Glovsky, and Popeo, P.C.
COUNSEL NOT ADMITTED TO USDC - NJ BAR, 44 Montgomery Street
MINTZ, LEVIN, COHEN, FERRIS, GLOVSKY AND POPEO, P.C.
COUNSEL NOT ADMITTED TO USDC - NJ BAR, ONE FINANCIAL CENTER
MINTZ, LEVIN, COHN, FERRIS, GLOVSKY AND POPEO, P.C.
COUNSEL NOT ADMITTED TO USDC-NJ BAR, ONE FINANCIAL CENTER
Mintz, Levin, Cohn, Ferris, Glovsky, and Popeo, P.C.
COUNSEL NOT ADMITTED TO USDC - NJ BAR, One Financial Center
Consolidated Defendant
CIPLA USA, INC. Operating Company
Represented By
1 Attorneys ListedSTONE CONROY LLC
STONE CONROY LLC, 25A HANOVER ROAD
CIPLA LTD. Operating Company
Represented By
1 Attorneys ListedSTONE CONROY LLC
STONE CONROY LLC, 25A HANOVER ROAD
Court & Judges
Court
District Court, D. New Jersey (njd)
Presiding Judge
Global Patent Family Cross-Litigation Radar
CasLoc 360° Radar 25 Family MembersMulti-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions
| Jurisdiction | Publication Number | Relationship | Official Record |
|---|---|---|---|
| 🇺🇸 United States | Asserted | US Continuation / Sibling | View Official Patent → |
| 🇩🇪 Germany | Germany Counterpart | View Official Patent → | |
| 🇰🇷 South Korea | South Korea Counterpart | View Official Patent → | |
| 🇰🇷 South Korea | South Korea Counterpart | View Official Patent → | |
| 🇪🇺 European Patent Office (UPC States) | European Counterpart (EP) | View Official Patent → | |
| 🇪🇺 European Patent Office (UPC States) | European Counterpart (EP) | View Official Patent → | |
| 🇪🇺 European Patent Office (UPC States) | European Counterpart (EP) | View Official Patent → | |
| 🇪🇺 European Patent Office (UPC States) | European Counterpart (EP) | View Official Patent → | |
| 🇰🇷 South Korea | South Korea Counterpart | View Official Patent → | |
| 🇰🇷 South Korea | South Korea Counterpart | View Official Patent → | |
| 🇨🇳 China | China Counterpart | View Official Patent → | |
| 🇨🇳 China | China Counterpart | View Official Patent → | |
| 🇨🇳 China | China Counterpart | View Official Patent → | |
| 🇨🇳 China | China Counterpart | View Official Patent → | |
| 🌐 PCT International (WIPO) | PCT World Application | View Official Patent → |
No active co-pending lawsuits found across other jurisdictions for this family. All related sibling filings are currently unlitigated.
Patents Involved
There are 8 patents involved in this case.
| Patent Asset | Filing & Issue Date | Expiration & Term Status | External Links |
|---|---|---|---|
|
US10576156
Compositions for drug administration
|
Filed: 2018-02-06
Issued: 2020-03-03
|
Active (11.2 yrs remaining)
Expires: 2038-02-06
|
|
|
US10682414
Intranasal epinephrine formulations and methods for the treatment of disease
|
Filed: 2019-05-22
Issued: 2020-06-16
|
Active (12.5 yrs remaining)
Expires: 2039-05-22
|
|
|
US11173209
Compositions for drug administration
|
Filed: 2019-11-08
Issued: 2021-11-16
|
Active (13.0 yrs remaining)
Expires: 2039-11-08
|
|
|
US11191838
Intranasal epinephrine formulations and methods for the treatment of disease
|
Filed: 2020-05-07
Issued: 2021-12-07
|
Active (13.5 yrs remaining)
Expires: 2040-05-07
|
|
|
US11717571
Intranasal epinephrine formulations and methods for the treatment of disease
|
Filed: 2022-10-26
Issued: 2023-08-08
|
Active (12.2 yrs remaining)
Expires: 2039-02-06
|
Patent Enforceability & Injunction Risk Assessment
Active Threat — Patent is within enforceable statutory term; injunctive relief viable.
Standard Statutory Term — No obviousness-type double patenting noted.
Under 35 U.S.C. § 286, damages cannot accrue for infringement prior to 6 years before filing. 4th Year Maintenance Fee Paid (8th Year Window Upcoming).
Procedural Motions & Interlocutory Orders
Total Motions
33
Dispositive
9
Granted
18
Denied
1
Pending / Review
9
Motions by Category
Key Dispositive Motions & Rulings